BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8878462)

  • 1. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.
    Inui A; Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M
    Jpn J Cancer Res; 1996 Sep; 87(9):977-84. PubMed ID: 8878462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2.
    Yamamoto A; Sawada T; Yamashita Y; Nishihara T; Ho JJ; Kim Y; Chung KH
    Oncol Rep; 1999; 6(1):179-84. PubMed ID: 9864424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer.
    Cardillo TM; Ying Z; Gold DV
    Clin Cancer Res; 2001 Oct; 7(10):3186-92. PubMed ID: 11595713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
    Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor localization and biodistribution with radiolabeled monoclonal antibody against pancreatic cancer in tumor-bearing nude mice.
    Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M
    Tohoku J Exp Med; 1992 Oct; 168(2):397-401. PubMed ID: 1306326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biodistribution of radiolabeled F(ab')2 fragment of monoclonal antibody Nd2 and gamma-interferon enhancement on tumor localization in nude mice with human pancreatic tumor xenografts].
    Kondo Y
    Nihon Geka Gakkai Zasshi; 1995 Feb; 96(2):97-105. PubMed ID: 7708049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment.
    Kamigaki T; Yamamoto M; Ohyanagi H; Ohya M; Shimazoe T; Kono A; Ohtani W; Narita Y; Ohkubo M; Saitoh Y
    Jpn J Cancer Res; 1995 Dec; 86(12):1216-23. PubMed ID: 8636013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4.
    Maeda M; Shoji M; Kawagoshi T; Futatsuya R; Honda T; Brady LW
    Cancer; 1994 Feb; 73(3 Suppl):800-7. PubMed ID: 8306263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice.
    Mittal BB; Zimmer AM; Sathiaseelan V; Rosen ST; Radosevich JA; Rademaker AW; Saini A; Pierce MC; Webber DI; Spies SM
    Cancer; 1992 Dec; 70(12):2785-91. PubMed ID: 1451056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
    Andratschke M; Gildehaus FJ; Johannson V; Schmitt B; Mack B; Reisbach G; Lang S; Lindhofer H; Zeidler R; Wollenberg B; Luebbers CW
    Anticancer Res; 2007; 27(1A):431-6. PubMed ID: 17352264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.
    Sugyo A; Tsuji AB; Sudo H; Okada M; Koizumi M; Satoh H; Kurosawa G; Kurosawa Y; Saga T
    PLoS One; 2015; 10(4):e0123761. PubMed ID: 25893775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
    Stein R; Govindan SV; Chen S; Reed L; Richel H; Griffiths GL; Hansen HJ; Goldenberg DM
    J Nucl Med; 2001 Jun; 42(6):967-74. PubMed ID: 11390564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer.
    Alisauskus R; Wong GY; Gold DV
    Cancer Res; 1995 Dec; 55(23 Suppl):5743s-5748s. PubMed ID: 7493339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.
    Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Yamamoto W; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
    Jpn J Cancer Res; 1998 Aug; 89(8):870-8. PubMed ID: 9765625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
    Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
    Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma.
    Li GP; Zhang H; Zhu CM; Zhang J; Jiang XF
    World J Gastroenterol; 2005 Oct; 11(40):6288-94. PubMed ID: 16419157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4.
    Gold DV; Cardillo T; Vardi Y; Blumenthal R
    Int J Cancer; 1997 May; 71(4):660-7. PubMed ID: 9178823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4.
    Gold DV; Alisauskas R; Sharkey RM
    Cancer Res; 1995 Mar; 55(5):1105-10. PubMed ID: 7866995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.